Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer
NCT03063125 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2021-08-03
Summary
The purpose of this study is to examine the relationship between testosterone level changes around the time of radical cystectomy.
Conditions
- Bladder Cancer
- Low Testosterone Levels
Sponsors & Collaborators
-
University of Kansas Medical Center
lead OTHER
Principal Investigators
-
Jeffrey Holzbeierlein, MD · University of Kansas Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-03-31
- Primary Completion
- 2018-04-20
- Completion
- 2018-04-20
Countries
- United States
Study Locations
More Related Trials
-
Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients
NCT00965341 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy
NCT04833426 ·Status: RECRUITING ·Phase: PHASE3
-
Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17
NCT06312761 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Study of the Effect of Testosterone Treatment on Metabolic Parameters and Urinary Symptoms in Bariatric Patients
NCT02248467 ·Status: COMPLETED
-
BAseLine TEstosterone as a Prognostic and/or Predictive bioMARKer in mHSPC
NCT05530395 ·Status: NOT_YET_RECRUITING
-
Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes
NCT00529230 ·Status: TERMINATED
-
Symptoms and Clinical Signs of Hypogonadism in Testicular Cancer Survivors
NCT02240966 ·Status: COMPLETED
-
Testosterone Effects on Bone and Frailty
NCT00182871 ·Status: COMPLETED ·Phase: PHASE4
-
7 Tesla MRI Neuroimaging in Testicular Cancer Patients With Hypogonadism and on Androgen Replacement Therapy
NCT06191575 ·Status: SUSPENDED
-
Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
NCT04301765 ·Status: RECRUITING ·Phase: PHASE2
-
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
NCT04049331 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Testosterone, Cognition, Ageing, and Cancer
NCT03452436 ·Status: COMPLETED
-
Short-term Testosterone Replacement in Testicular Cancer Survivors
NCT03339635 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-Response of Gonadal Steroids and Bone Turnover in Older Men
NCT00114114 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Hypogonadism in Male Cancer Patients
NCT00472940 ·Status: COMPLETED
-
Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer
NCT00056654 ·Status: COMPLETED ·Phase: NA
-
Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality-Obs
NCT04630275 ·Status: COMPLETED
-
Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men
NCT05773183 ·Status: UNKNOWN
-
Plasma RBP Levels in Patients With Idiopathic Hypogonadotrophic Hypogonadism
NCT01758094 ·Status: COMPLETED
-
Testosterone-Dependent Effects on Protein Biomarkers From Healthy Males
NCT03541395 ·Status: COMPLETED ·Phase: NA
-
Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men
NCT00431197 ·Status: COMPLETED ·Phase: PHASE1
-
Cycled Testosterone Replacement Study
NCT00957528 ·Status: COMPLETED ·Phase: PHASE1
-
Does Testosterone Improve Function in Hypogonadal Older Men
NCT00304213 ·Status: WITHDRAWN ·Phase: PHASE4
-
TDSM- Testosterone Dose Response in Surgically Menopausal Women
NCT00494208 ·Status: COMPLETED ·Phase: NA
-
Testosterone Administration and ACL Reconstruction in Men
NCT01595581 ·Status: COMPLETED ·Phase: PHASE3